Our subsequent feedback experiments determined that the use of miR-370-5p inhibitor promoted cell proliferation, migration, and invasion and inhibited cell apoptosis in glioma cells with CHRM3-AS2 knocked down. The gene discussed is CHRM3; the disease is central nervous system cancer.